Pacelli et al., after a median observation time of 33 months in a cohort of 109 patients of CML, confirmed that CD26+ LSCs are detectable at the time of TKI discontinuation and also during TFR. Here, DPP4 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.